Melatonin modulates the expression of a number of genes related to inflammation and immunity. Declining levels of melatonin with age may thus relate to some of the changes in immune function that occur with age. mRNA expression levels in murine CNS were measured using oligonucleotide microarrays in order to determine whether a dietary melatonin supplement may modify age-related changes in the response to an inflammatory challenge. CB6F1 male mice were fed 40-ppm melatonin for 9 weeks prior to sacrifice at 26.5 months of age, and compared with age-matched untreated controls and 4.5-month-old controls. A subset of both young and old animals was injected i.p. with lipopolysaccharide (LPS). After 3 h, total RNA was extracted from whole brain (excluding brain stem and cerebellum), and individual samples were hybridized to Affymetrix Mouse 430-2.0 arrays. Data were analyzed in Dchip and GeneSpring. Melatonin treatment markedly altered the response in gene expression of older animals subjected to an LPS challenge. These changes in general, caused the response to more closely resemble that of young animals subjected to the same LPS challenge. Thus melatonin treatment effects a major shift in the response of the CNS to an inflammatory challenge, causing a transition to a more youthful mRNA expression profile.
Introduction
Melatonin (N-acetyl-5-methoxytryptamine) is a shortlived indole produced by the pineal gland during the dark phase of the photoperiod. This neurohormone possesses a number of important biological activities including its action as an endogenous synchronizer. Many studies have identified a regulatory role for melatonin in the immune system (Nelson et al., 1995) . Melatonin may also attenuate some aspects of aging (Pierpaoli and Regelson, 1994; Sharman et al., 2004) . In aged mice, melatonin treatment can rejuvenate the involuted thymus and partially restore peripheral immune functions (Tian et al., 2003) . A greater proportion of old mice than of young succumbs to an i.p. injection of LPS (Saito et al., 2003) . Melatonin also increases the survival rate of young mice injected with an otherwise lethal dose of LPS (Carrillo-Vico et al., 2005) . The age-related decline in amplitude of circadian melatonin secretion is especially pronounced in aged demented subjects and the decline of its nocturnal peak is correlated with the severity of cognitive impairment (Magri et al., 2004) .
The biological activity of melatonin is brought about in part by two high affinity G protein coupled receptors (GPCRs) Mtnr1a and Mtnr1b, by quinone 2 NAD(P)H dehydrogenase (NQO2), and by nuclear receptors RZR/ROR. Inflammatory cytokine expression is also modulated by melatonin; for example, IL-2 production by Jurkat cells from human leukemia, is enhanced by way of a nuclear receptor-mediated mechanism (Guerrero et al., 2000) . Melatonin also reduces IL-6 secretion in amyloid β peptide-treated brain slices, in a concentration dependent manner (Clapp-Lilly et al., 2001) . Inflammatory processes in the CNS are increased with normal aging (Joseph et al., 2005) , and elevated astroglial activation 
